US Patent

US8790708 — Coated tablet formulations and uses thereof

Method of Use · Assigned to Wyeth LLC · Expires 2030-11-05 · 4y remaining

Vulnerability score 51/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects coated tablet formulations of neratinib maleate and methods for making such tablets.

USPTO Abstract

The present invention provides coated tablet formulations comprising neratinib maleate, and improved methods for making such coated tablets.

Drugs covered by this patent

neratinib-maleate (NERATINIB MALEATE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2043`	—	neratinib-maleate

Patent Metadata

Patent number: US8790708
Jurisdiction: US
Classification: Method of Use
Expires: 2030-11-05
Drug substance claim: No
Drug product claim: Yes
Assignee: Wyeth LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.